Literature DB >> 23737595

Inflammatory myopathy as the initial presentation of cryoglobulinaemic vasculitis.

Noelia Rodríguez-Pérez1, Yerania Rodríguez-Navedo, Yvonne M Font, Luis M Vilá.   

Abstract

Cryoglobulinaemic vasculitis is characterised by immunoglobulin deposition at low temperatures. The most common manifestations are cutaneous involvement, arthralgias, Raynaud's phenomenon, peripheral neuropathy and renal disease. Myopathy is unusual and only a few cases have been reported. Here, we present a 31-year-old woman who developed progressive muscle weakness involving upper and lower extremities, dysphagia, paraesthesias and palpable purpura. Diagnostic studies revealed elevated creatine kinase, diffuse myopathic and sensorimotor axonal neuropathy on electromyography and nerve conduction studies, and inflammatory myopathy on muscle biospsy. Cryoglobulin levels were elevated on two occasions. She responded favourably to cyclophosphamide and high-dose corticosteroids. Cyclophosphamide was continued for 1 year followed by methotrexate. Prednisone was gradually tapered and discontinued 1 year later. She remained in clinical remission after 4 years of follow-up. This case suggests that cryoglobulinaemia should be considered in the differential diagnosis of a patient presenting with inflammatory myopathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23737595      PMCID: PMC3702929          DOI: 10.1136/bcr-2013-010117

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Cryoglobulinemia vasculitis: an update.

Authors:  Benjamin Terrier; Patrice Cacoub
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

2.  Clinical spectrum of cryoglobulinaemic neuropathy.

Authors:  F Gemignani; F Brindani; S Alfieri; T Giuberti; I Allegri; C Ferrari; A Marbini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 3.  Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.

Authors:  Floranne C Ernste; Ann M Reed
Journal:  Mayo Clin Proc       Date:  2013-01       Impact factor: 7.616

4.  Polymyositis with plasma cell infiltrate in essential mixed cryoglobulinaemia.

Authors:  C Voll; L C Ang; J Sibley; R Card; K Lefevre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

5.  Interstitial lung disease and cryoglobulinemia in polymyositis.

Authors:  P B Lambie; F P Quismorio
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

6.  Peripheral neuropathy in essential mixed cryoglobulinaemia.

Authors:  F Gemignani; G Pavesi; A Fiocchi; P Manganelli; G Ferraccioli; A Marbini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

Review 7.  Symptomatic cryoglobulinemia.

Authors:  A Dispenzieri
Journal:  Curr Treat Options Oncol       Date:  2000-06
  7 in total
  1 in total

1.  A Flare of Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis After COVID-19.

Authors:  Kenya Hamazaki; Daichi Umemoto; Tomohiro Asada; Maki Iwatani; Kazuyuki Tsuboi; Koji Oh; Hiroki Konishi
Journal:  Cureus       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.